NSE: WOCKPHARMA | BSE: 532300

Expensive Performer

Download real time

1389.70 1.40 (0.10%)

25.64% Fall from 52W High

67,582 NSE+BSE Volume

NSE 14 Oct, 2025 10:23 AM (IST)

22,581.5

Market Cap

High in industry

1.6

Beta 1Year

Very High Volatility

Wockhardt Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for WOCKPHARMA, BSE:532300 Wockhardt Ltd.

Search Inside the pdf :

Wockhardt Ltd.

08 Jul 2025

1389.70

0.10%

Axis Punch:Wockhardt

Buy: Wockhardt Ltd.

Axis Direct

We recommend a BUY rating on the stock, with a target price of Rs 1,870/share reflecting 10% upside potential from the CMP.

Number of FII/FPI investors increased from 171 to 186 in Jun 2025 qtr.

Wockhardt Ltd.

31 Jan 2018

1389.70

0.10%

Wockhardt Ltd Q3FY18 results comment

Results Update: Wockhardt Ltd.

HDFC Securities

Wockhardt Ltd Q3FY18 results comment Revenue decreased by 1.66% to Rs. 1005.3 Cr in Q3FY18 when compared to the previous quarter

Number of FII/FPI investors increased from 171 to 186 in Jun 2025 qtr.

Wockhardt Ltd.

23 May 2017

1389.70

0.10%

Wockhardt Ltd Q4FY17 results comment

Results Update: Wockhardt Ltd.

HDFC Securities

Revenue fell by 13.26% to Rs. 863.53 Cr in Q4FY17 when compared to the previous quarter.

Wockhardt Ltd. is trading below all available SMAs

Wockhardt Ltd.

31 Jan 2017

1389.70

0.10%

Wockhardt Ltd Q3FY17 results comment

Results Update: Wockhardt Ltd.

HDFC Securities

Revenue fell by 6.49% to Rs. 995.56 Cr in Q3FY17 when compared to the previous quarter. Also, it decreased by 7.35% when compared with Q3FY16.

Number of FII/FPI investors increased from 171 to 186 in Jun 2025 qtr.

Is Wockhardt Ltd. worth buying?

451 Votes:

Buy 73.61%

Sell 17.07%

Hold 9.31%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Results Update SEE REPORTS >

pdf